Share of Clicks for top 10 US Pharma & Biotech Oncology brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| themmrf.org | 5.11 |
| kisqali-hcp.com | 4.2 |
| mayoclinic.org | 4.14 |
| keytruda.com | 4.02 |
| kisqali.com | 3.99 |
| lilly.com | 2.87 |
| ibrance.com | 2.54 |
| breyanzi.com | 2.4 |
| imbcr.org | 2.2 |
| epkinly.com | 2.13 |
| others | 66.4 |
- themmrf.org - 5.11%
- kisqali-hcp.com - 4.2%
- mayoclinic.org - 4.14%
- keytruda.com - 4.02%
- kisqali.com - 3.99%
- lilly.com - 2.87%
- ibrance.com - 2.54%
- breyanzi.com - 2.4%
- imbcr.org - 2.2%
- epkinly.com - 2.13%
- others - 66.4%
Copyright © Adthena. All rights reserved.
In the oncology PPC landscape, ‘others’ dominate with 66.4% click share, overshadowing top contenders like themmrf.org at 5.11% and kisqali-hcp.com at 4.2%.
Share of Spend for the top 10 US Pharma & Biotech Oncology brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | kisqali.com | kisqali-hcp.com | keytruda.com | themmrf.org | mayoclinic.org | lilly.com | breyanzi.com | opdivo.com | trodelvy.com | ibrance.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/05/01 | 13.88% | 9.06% | 3.69% | 3.61% | 2.21% | 3.27% | 2.96% | 2.34% | 1.97% | 4.69% |
| 2026/05/02 | 9.14% | 7.13% | 3.84% | 3.73% | 1.49% | 3.1% | 2.52% | 2.86% | 2.05% | 4.17% |
| 2026/05/03 | 10.66% | 8.27% | 4.21% | 2.87% | 2.64% | 2.77% | 3.1% | 2.3% | 1.89% | 4.64% |
| 2026/05/04 | 10.6% | 7.59% | 3.6% | 1.96% | 1.89% | 3.32% | 3.11% | 2.17% | 1.98% | 4.7% |
| 2026/05/05 | 8.12% | 6.21% | 4.16% | 6.81% | 2% | 2.51% | 3.33% | 2.23% | 2.13% | 4.2% |
| 2026/05/06 | 9.75% | 7.09% | 2.12% | 4.53% | 2.01% | 3.59% | 2.07% | 1.87% | 1.78% | 2.86% |
| 2026/05/07 | 12.02% | 8.94% | 2.45% | 3.41% | 2% | 3.93% | 3.07% | 1.33% | 2.53% | 3.51% |
| 2026/05/08 | 12.48% | 8.13% | 3.75% | 4.48% | 1.22% | 3.42% | 2.12% | 2.13% | 2.17% | 3.71% |
| 2026/05/09 | 7.26% | 6.51% | 3.8% | 4.55% | 1.25% | 3.46% | 2.01% | 2.5% | 2.26% | 3.95% |
| 2026/05/10 | 6.58% | 5.95% | 4.56% | 3.13% | 3.17% | 3.4% | 1.74% | 2.71% | 2.25% | 4.3% |
| 2026/05/11 | 9.24% | 6.84% | 3.12% | 7.65% | 1.69% | 2.96% | 1.88% | 2.12% | 1.97% | 2.52% |
| 2026/05/12 | 10.32% | 7.11% | 3.62% | 4.07% | 1.76% | 2.91% | 1.92% | 2.21% | 2.19% | 3.08% |
| 2026/05/13 | 10.87% | 8.18% | 3.39% | 6.62% | 1.81% | 3.08% | 1.62% | 2.1% | 2.53% | 3.31% |
| 2026/05/14 | 10.95% | 6.75% | 3.72% | 4.79% | 3.21% | 3.62% | 1.84% | 2.42% | 2.05% | 2.97% |
| 2026/05/15 | 12.45% | 8.11% | 3.74% | 4.47% | 1.22% | 3.41% | 2.12% | 2.12% | 2.16% | 3.7% |
| 2026/05/16 | 8.6% | 6.54% | 3.51% | 4.7% | 3.77% | 3.07% | 2.06% | 2.31% | 2.19% | 2.57% |
| 2026/05/17 | 10.55% | 6.79% | 3.46% | 3.39% | 4.13% | 3.09% | 1.71% | 2.42% | 2.49% | 2.65% |
| 2026/05/18 | 9.88% | 6.73% | 4.17% | 3.18% | 3.23% | 3.4% | 1.72% | 2.12% | 2.16% | 3.01% |
| 2026/05/19 | 11.06% | 6.55% | 3.48% | 4.34% | 3.98% | 2.55% | 2.06% | 2.22% | 2.49% | 3.4% |
| 2026/05/20 | 9.21% | 5.73% | 3.56% | 6.96% | 3.28% | 3.21% | 1.6% | 2.02% | 2.49% | 2.77% |
| 2026/05/21 | 8.63% | 6.23% | 3.18% | 3.75% | 2.58% | 3.05% | 1.59% | 2.1% | 1.97% | 2.32% |
| 2026/05/22 | 8.11% | 6.38% | 3.52% | 3.15% | 3.41% | 3.78% | 1.85% | 2.42% | 2.16% | 2.93% |
| 2026/05/23 | 7.55% | 5.77% | 3.88% | 5.09% | 3.01% | 2.9% | 1.85% | 2.23% | 2.15% | 2.95% |
| 2026/05/24 | 9.61% | 6.68% | 3.29% | 2.84% | 3.12% | 3.03% | 2.19% | 1.92% | 1.95% | 3.02% |
| 2026/05/25 | 8.92% | 5.38% | 3.98% | 3.06% | 2.69% | 3.08% | 1.86% | 2.05% | 2.26% | 3.14% |
| 2026/05/26 | 8.68% | 4.13% | 3.14% | 3.82% | 5.05% | 2.63% | 2.01% | 1.99% | 1.83% | 2.58% |
| 2026/05/27 | 10.21% | 6.55% | 3.84% | 2.52% | 4.91% | 3% | 2.75% | 1.83% | 1.9% | 2.54% |
| 2026/05/28 | 7.96% | 7.32% | 4.19% | 3.43% | 3.1% | 3.41% | 1.89% | 1.92% | 1.91% | 2.56% |
| 2026/05/29 | 9.48% | 7.26% | 3.44% | 3.11% | 2.2% | 3.57% | 2.2% | 1.84% | 1.91% | 2.08% |
| 2026/05/30 | 7.75% | 6.99% | 3.56% | 4.28% | 2.57% | 3.12% | 2.44% | 1.9% | 1.73% | 2.26% |
| 2026/05/31 | 7.89% | 6.7% | 3.72% | 3.25% | 3.1% | 2.94% | 2.44% | 2.4% | 1.96% | 1.95% |
- kisqali.com
- kisqali-hcp.com
- keytruda.com
- themmrf.org
- mayoclinic.org
- lilly.com
- breyanzi.com
- opdivo.com
- trodelvy.com
- ibrance.com
Copyright © Adthena. All rights reserved.
In May 2026, kisqali.com led with fluctuating spend, peaking early at 13.88%. Kisqali-hcp.com and keytruda.com followed, showing steady trends. Themmrf.org spiked mid-month, while mayoclinic.org and lilly.com maintained moderate levels. Breyanzi.com and opdivo.com had consistent low spend, with trodelvy.com and ibrance.com trailing. The month ended with kisqali.com still dominant.
Competitor Count for US Pharma & Biotech Oncology
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2026/05/01 | 413 |
| 2026/05/02 | 410 |
| 2026/05/03 | 415 |
| 2026/05/04 | 427 |
| 2026/05/05 | 428 |
| 2026/05/06 | 410 |
| 2026/05/07 | 425 |
| 2026/05/08 | 416 |
| 2026/05/09 | 407 |
| 2026/05/10 | 416 |
| 2026/05/11 | 434 |
| 2026/05/12 | 439 |
| 2026/05/13 | 443 |
| 2026/05/14 | 450 |
| 2026/05/15 | 416 |
| 2026/05/16 | 435 |
| 2026/05/17 | 438 |
| 2026/05/18 | 450 |
| 2026/05/19 | 433 |
| 2026/05/20 | 432 |
| 2026/05/21 | 443 |
| 2026/05/22 | 436 |
| 2026/05/23 | 442 |
| 2026/05/24 | 439 |
| 2026/05/25 | 455 |
| 2026/05/26 | 457 |
| 2026/05/27 | 474 |
| 2026/05/28 | 455 |
| 2026/05/29 | 460 |
| 2026/05/30 | 450 |
| 2026/05/31 | 455 |
Copyright © Adthena. All rights reserved.
In May 2026, distinct advertisers on Google SERP began at 413, fluctuated, and peaked at 474. The month concluded with a strong presence of 455 advertisers.
